Maria Soledad Cortina

Maria Soledad Cortina

Auto-generated profile, based on publicly available information

Maria Soledad Cortina

Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL; and

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2020 in Clinical Ophthalmology
Verified
Journal Article
Open access
PDF file
MNManachai Nonpassopon
Manachai Nonpassopon
MNMuanploy Niparugs
Muanploy Niparugs
MCMaria Soledad Cortina
Maria Soledad Cortina
The use of Boston type 1 keratoprosthesis (BKPro) has significantly increased worldwide. It is no longer considered a procedure of last resort but a reasonable option for patients with otherwise poor prognosis for a traditional penetrating keratoplasty. BKPro was approved by the Food and Drug Administration in 1992 for bilateral severe corneal blindness due to multiple corneal transplant failure. Over the years, indications have extended beyond recurrent immunologic rejection to include other conditions such as chemical injury and other causes of bilateral limbal stem cell deficiency, extensive corneal neovascularization, neurotrophic corneas and hypotony, among others. Numerous advances in the design of the BKPro, improvement of preoperative, intraoperative and postoperative management have resulted in favorable outcomes and a reduction in postoperative complications. Accordingly, many studies have shown that implantation of this device is highly effective in restoring vision with very good short-term outcomes. However, due to the lifetime risk of sight-threatening complications after BKPro implantation, a longer follow-up period should provide outcomes that are more realistic. In this review, the authors examined only the results of publications with an average of at least 2 years of follow-up. The overall intermediate to long-term visual outcomes and retention rate in BKPro seem to be favorable. However, autoimmune diseases and cicatrizing conditions continue to show a higher incidence of postoperative complications that require further management.

1 October 2013 in Cornea
Verified
Journal Article
Closed access
JKJoann J. Kang
Joann J. Kang
NANorma Allemann
Norma Allemann
JCJose de la Cruz
Jose de la Cruz
MCMaria Soledad Cortina
Maria Soledad Cortina
Purpose: To analyze iris behavior and angle status using serial anterior segment optical coherence tomography (AS-OCT) after Boston keratoprosthesis (KPro). Methods: A prospective cases series consisted of 11 eyes with implanted type 1 KPro at a tertiary care institution. The patients underwent preoperative and serial postoperative AS-OCT imaging. The main outcome measures included anterior chamber angle (ACA) at representative meridians (0 degrees, 45 degrees, 90 degrees, 135 degrees, 180 degrees, 225 degrees, 270 degrees, and 315 degrees), grading of total ACA as open (>10 degrees), shallow (≥1 degrees and ≤10 degrees) or closed (<1 degrees), preoperative anterior chamber depth (ACD), postoperative anatomical and functional ACD, and the presence of iris-back plate touch and peripheral anterior synechiae. Results: The mean follow-up with serial AS-OCT was 13.1 months. Preoperatively, 54.5%, 27.3%, and 18.2% of the eyes had open, shallow, and closed angles, respectively. The mean change in the effective ACD decreased postoperatively by 1.61 mm. At 0 degree and 180 degree meridians, the ACA decreased by a mean change of 6.95 degrees and 8.40 degrees, with a mean change of 8.12 degrees for all meridians. Eight (72.7%) eyes had synechiae with 7.3 and 6.7 clock hours of peripheral anterior synechiae and iris-back plate touch. At the last follow-up, 7 (63.6%) eyes had considerable progression of angle closure (change in grading of total angle), and 18.2%, 36.4%, and 45.5% had open, shallow, and closed angles, respectively. Conclusions: KPro implantation induced progressive angle closure, shallowing of the anterior chamber, and synechiae formation that is not visible on clinical examination. Serial AS-OCT plays an important role in the detection and monitoring of progressive angle closure, and clinical correlation is needed to assess the association with glaucoma development or progression.

1 February 2020 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
GYGhasem Yasdanpanah
Ghasem Yasdanpanah
KBKelley J. Bohm
Kelley J. Bohm
OHOmar M. Hassan
Omar M. Hassan
FKFaris I. Karas
Faris I. Karas
AEAbdelrahman Elhusseiny
Abdelrahman Elhusseiny
ADAli Djalilian
Ali Djalilian

6 February 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KKKai B Kang
Kai B Kang
FKFaris I Karas
Faris I Karas
RRRuju Rai
Ruju Rai
JHJoelle A Hallak
Joelle A Hallak
JKJoann J Kang
Joann J Kang
MCMaria S Cortina
Maria S Cortina
Despite improved retention and reduced complication rates paving the way for the current expansion of applications and surge in prevalence for the Boston type I Keratoprosthesis (KPro), the most frequent indication for its implantation today remains prior graft failure. The purpose of this study is to evaluate the long-term outcomes of primary KPro and compare to secondary implantation in a matched cohort study. This study included patients who underwent KPro implantation in a single center by two surgeons between July 2008 and October 2014. All eyes with KPro implantation as the primary procedure with a minimum follow up of 12 months were matched with eyes with same preoperative diagnoses that underwent secondary KPro implantation. Main outcomes included visual acuity and device retention. A total of 56 eyes were included with 28 eyes in each group. Mean follow up was 5.0 years for both groups. Twenty-nine percent (8) of the eyes in the primary group had a diagnosis of chemical or thermal injuries, 25% (7) aniridia, 18% (5) autoimmune disease, 4% (1) infectious keratitis/neurotrophic cornea, 7% (2) gelatinous corneal dystrophy, 7% (2) ectrodactyly ectodermal dysplasia/limbal stem cell deficiency, and 11% (3) uveitis/hypotony. Sixty-one percent (17) of the eyes in the primary group and 39% (11) in the secondary group maintained a final best-corrected visual acuity of 20/200 or better at a mean follow up of 5.0 years; the probability of maintaining best-corrected vision is 0.83 and 0.49 for primary and secondary groups at 5.0 years (p = 0.02). There is no statistically significant difference between groups in device retention (p = 0.22) or postoperative complication rates (p >0.05). This study demonstrates that Boston KPro implantation may be successful as a primary procedure in patients at high risk of failure with traditional penetrating keratoplasty. The device has a good long-term retention rate and visual outcomes are promising however a larger study is needed for more definitive results.

1 October 2020 in The Ocular Surface
Verified
Journal Article
Closed access
JPJennifer Park
Jennifer Park
PPPakornkit Phrueksaudomchai
Pakornkit Phrueksaudomchai
MCM. Soledad Cortina
M. Soledad Cortina

1 April 2019 in The Ocular Surface
Verified
Journal Article
Closed access
SJSayena Jabbehdari
Sayena Jabbehdari
TSTaylor W. Starnes
Taylor W. Starnes
KKKhaliq H. Kurji
Khaliq H. Kurji
MEMedi Eslani
Medi Eslani
MCMaria S. Cortina
Maria S. Cortina
ADAli Djalilian
Ali Djalilian